Key facts
- Notable investors include Innoangel Fund, YuanBio Venture Capital, Xiamen Financing Guarantee, China Prosperity Capital, DYEE Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Innovision (China)
- ·The full record, as it builds
Funding rounds
No funding rounds for Innovision (China) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Innovision (China)
Developer of auxiliary diagnosis and treatment systems designed to meet the clinical needs of endoscopy centers in various hospitals. The company's systems apply artificial intelligence deep learning to medical imaging-assisted diagnosis of the digestive system to process digestive endoscopy image data, enabling hospitals to improve work efficiency and reduce the workload and redundant labor of doctors.
- Sector
- Healthcare
- HQ
- Xiamen, China
- Founded
- 2017
- Website
- innovsight.com/
- Ownership
- Privately Held (backing)
Innovision (China) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Innovision (China) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Innovision (China) in its N-PORT filings yet. We sweep new filings monthly.